Post Mastectomy Lymphedema
Conditions
Keywords
Chest, Lymphedema, Post mastectomy, Myofasical release, Pain
Brief summary
This study aims to determine the combined effect of resisted deep breathing and Myofascial release on pain, respiratory efficiency, chest mobility and lymph edema in Postmastectomy.
Detailed description
The study will be randomized controlled trial and will conducted in Shokat Khanam hospital and Anmol cancer hospital. Non-probability convenience sampling technique will be used and 48 participants will be recruited in study after randomization. The subjects will be divided into two group. Group A will receive myofascial release. Group B will receive myofascial release with resisted deep breathing. Both Group will receive Baseline treatment which is including transcutaneous electrical nerve stimulation. The total duration of treatment will be 12 weeks and there will be 2 sessions each week. The tools that will be used are Numeric Pain Rating Scale (NPRS) for pain, Circumferential limb measurements for chest mobility or lymph edema and Spirometer for respiratory efficiency. After data collection will be analyzed by using SPSS version 21.
Interventions
OTHERResisted Deep Breathing
The total duration of treatment will be 12 weeks and there will be 2 sessions each week
OTHERMyofascial release
The total duration of treatment will be 12 weeks and there will be 2 sessions each week
Sponsors
Riphah International University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
45 Years to 64 Years
Healthy volunteers
Yes
Inclusion criteria
* Radiation therapy and chemotherapy was finished at least three months * 6 months after mastectomy for breast cancer being diagnosed without lymphedema or with stage 1 lymphedema * Complete unilateral Mastectomy * pain and having one or more of the following symptoms: heaviness, numbness, oppression, stiffness, alterations in the function, or mobility of the limited shoulder range of motion.
Exclusion criteria
* Presence of shoulder pathologies for which surgical indications exist * Musculoskeletal injury in adjacent areas (shoulder or neck etc.) * bilateral surgery for the treatment of breast cancer * Bilateral lymphadenectomy * Open wounds on upper limbs * Circulatory disorders * History of shoulder surgery for reasons other than breast cancer.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Spirometer | 12th week | The evaluation of pulmonary function will be performed using conventional spirometry with a Spirobank USB spirometer (Medical International Research, Rome, Italy). The directly measured parameters will include lung volumes, capacities, and flow rates, assessed through the procedures of slow vital capacity (SVC), forced vital capacity (FVC), and maximal voluntary ventilation (MVV), performed in this order |
| Circumferential limb measurements | 12th week | In the proposed study, upper limb volume will be measured using circumference measurements. The anatomical positions of the arm will be selected at 7 cm intervals, including the wrist (the slenderest part), 7 cm above the wrist (lower arm), 7 cm below the elbow (lower arm), at the elbow, 7 cm above the elbow (upper arm), and at the same level as the axilla (upper arm). To minimize measurement error, all measurements will be taken at a constant pressure, with participants seated in a position where the hips and knees are bent at 90 degrees. |
| Numerical pain rating scale (NPRS) | 12th week | Subjective pain will be measured using the Numerical pain Rating Scale (NPRS), which is the simplest and most commonly used pain assessment tool. Patients will be asked to mark a point on a line ranging from 0 (no pain) to 10 (worst imaginable pain) to indicate their pain intensity. |
| Chest Mobility | 12th week | Chest circumference at maximal voluntary inspiration (insp) and maximal voluntary expiration (expir), as well as chest expansion (CE) calculated as the difference between insp and expir will be measured in a sitting position using a tape marked in 0.1 cm increments at the level of the fourth intercostal space. Participants will be instructed about the procedure and asked to exhale fully and hold for expir, and inhale deeply and hold for insp. The highest insp and lowest expir values from three attempts will be recorded, and their difference will represent chest expansion |
Countries
Pakistan
Contacts
CONTACTimran amjad
PRINCIPAL_INVESTIGATORhina gul, PhD*
Riphah International University
Outcome results
None listed